Page last updated: 2024-12-07
gi 90291
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
GI 90291: major metabolite of remifentanil [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 131560 |
CHEMBL ID | 1001 |
SCHEMBL ID | 1952247 |
MeSH ID | M0223421 |
Synonyms (20)
Synonym |
---|
unii-e1ezx4s2e1 |
1-piperidinepropanoic acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)- |
4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine propionic acid |
gr90291 |
gi 90291 |
gr-90291 |
e1ezx4s2e1 , |
remifentanil acid |
gi-90291 |
132875-68-4 |
gr 90291 |
gi90291 |
gr 90291c |
CHEMBL1001 |
3-[4-methoxycarbonyl-4-(n-propanoylanilino)piperidin-1-yl]propanoic acid |
SCHEMBL1952247 |
DTXSID60157827 |
remifentanil hydrochloride impurity c [ep impurity] |
3-(4-(methoxycarbonyl)-4-(phenyl(propanoyl)amino)piperidin-1-yl)propanoic acid |
PD057618 |
Research Excerpts
Pharmacokinetics
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" This suggests that remifentanil may not need to be dosed according to body weight in adult patients." | ( Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Hoke, JF; Hug, CC; Muir, KT; Sebel, PS; Westmoreland, CL, 1993) | 0.29 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (3)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID73902 | Inhibition of electrically evoked contraction in guinea pig ileum determined in vitro | 1991 | Journal of medicinal chemistry, Jul, Volume: 34, Issue:7 | Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. |
AID177922 | Analgesic effect calculated using in vivo rat tail withdrawal assay. | 1991 | Journal of medicinal chemistry, Jul, Volume: 34, Issue:7 | Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. |
AID174621 | Duration of analgesic effect calculated using in vivo rat tail withdrawal assay. | 1991 | Journal of medicinal chemistry, Jul, Volume: 34, Issue:7 | Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (90.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.68
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.68) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (10.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (90.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |